Form 4: Cara Therapeutics CEO Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Christopher Posner, CEO of Cara Therapeutics, sold 372 shares of common stock on February 4, 2025, to cover tax obligations related to vesting restricted stock units.
Summary
- Christopher Posner, the President and CEO of Cara Therapeutics, Inc., sold 372 shares of common stock on February 4, 2025.
- The sale was executed at a weighted average price ranging from $4.72 to $4.74 per share.
- The transaction was conducted under a pre-arranged 'sell to cover' arrangement adopted on November 2, 2022, to satisfy tax withholding obligations triggered by the vesting of restricted stock units.
- Following the transaction, Posner directly owns 13,692 shares of Cara Therapeutics.
- The reported number of securities beneficially owned reflects a 1-for-12 reverse stock split that occurred on December 30, 2024.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock transactions. It doesn't convey any particularly positive or negative sentiment about the company's performance or prospects.
Industry Context
This is a routine Form 4 filing, indicating insider activity related to stock sales for tax obligation fulfillment. It's common for executives to sell shares to cover taxes when restricted stock units vest.
Stakeholder Impact
- The sale of shares by the CEO could have a minor impact on shareholders, potentially creating slight downward pressure on the stock price in the short term.
Key Dates
| Date | Description |
|---|---|
| November 2, 2022 | Reporting Person adopted a 'sell to cover' arrangement in accordance with Rule 10b5-1. |
| December 30, 2024 | 1-for-12 reverse stock split was effected by the Issuer. |
| February 4, 2025 | Date of transaction: sale of 372 shares of common stock. |
| February 6, 2025 | Date of Form 4 filing. |
Keywords
Form 4, Christopher Posner, Cara Therapeutics, CARA, Insider Trading, Stock Sale, CEO, Tax Obligations, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.